Because Good Medicine Deserves Better Explanations
Knowing the role of VLDL (very low-density lipoprotein) and chylomicrons is a key factor in understanding how lipids (fats) and lipoproteins are involved in atherosclerotic cardiovascular disease (ASCVD). In the current era of adiposity and metabolic disease, VLDL has gained a bigger role than before and may help explain many of the disorders associated with the obesity epidemic such … Read more
Data presented at the World Heart Federation’s World Congress of Cardiology & Cardiovascular Health 2016 (WCC 2016) in Mexico City may radically change our perspective on how carbohydrates and different types of fats affect blood cholesterol and other lipid biomarkers. The presentation was based on data from the Prospective Urban Rural Epidemiological (PURE) study. The data have not been … Read more
Approximately 30 percent of people in the United States have a disease that is characterized by abnormal deposits of fat in the liver. The disease is not contagious, and unlike many other disorders of the liver, it is not caused by overconsumption of alcohol. It is called non-alcoholic fatty liver disease (NAFLD) and has become the leading cause of chronic liver disease … Read more
Saturated fat is the bad boy once again according to a paper recently published online in the Journal of the American College of Cardiology (1). The authors of the paper, led by Li Yanping from the Department of Nutrition at the Harvard School of Public Health, conclude that unsaturated fatty acids, especially polyunsaturated fatty acids (PUFAs) … Read more
Although regular intake of omega-3 fatty acids is believed to have several health benefits, some questions remain unanswered. Do we all need more omega-3 or just some of us? Is eating fish sufficient or do we need to take supplements? Is there a way to tell if the cells in our body are getting enough omega-3 or if we … Read more
